Creative Planning’s Medicines Co MDCO Stock Holding History

Creative Planning’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-2,000	Closed	-$6K	–	4491
2014 Q4	$6K	Hold	2,000	–	–	﹤0.01%	3442
2014 Q3	$1K	Buy	+2,000	New	+$50.8K	﹤0.01%	3904

Other funds holding MDCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Creative Planning's MDCO Position: Q4 2019 in Review

Creative Planning sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 66,742 shares — an estimated $3.34M sold.

Creative Planning first reported a position in MDCO in Q2 2013 and held it in 25 quarters. The position peaked at $5.74M in Q2 2017. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

Creative Planning reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
Creative Planning sold 66,742 Medicines Co shares in Q4 2019, an estimated $3.34M.
Creative Planning first reported a position in Medicines Co in Q2 2013 and held it in 25 quarters.
Creative Planning's Medicines Co position peaked at $5.74M in Q2 2017.
284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Creative Planning's 13F filing for Q4 2019, filed 30 Jan 2020.